S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Closing prices for crude oil, gold and other commodities
Comprehensive Analysis of PayPal Stock
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Closing prices for crude oil, gold and other commodities
Comprehensive Analysis of PayPal Stock
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Closing prices for crude oil, gold and other commodities
Comprehensive Analysis of PayPal Stock
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Closing prices for crude oil, gold and other commodities
Comprehensive Analysis of PayPal Stock
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline

ZIVO Bioscience (ZIVO) Competitors

$8.00
0.00 (0.00%)
(As of 04/19/2024 ET)

ZIVO vs. SRZN, APTO, AIM, EVAX, SNTI, NKGN, CRTX, IKT, COEP, and PLUR

Should you be buying ZIVO Bioscience stock or one of its competitors? The main competitors of ZIVO Bioscience include Surrozen (SRZN), Aptose Biosciences (APTO), AIM ImmunoTech (AIM), Evaxion Biotech A/S (EVAX), Senti Biosciences (SNTI), NKGen Biotech (NKGN), Cortexyme (CRTX), Inhibikase Therapeutics (IKT), Coeptis Therapeutics (COEP), and Pluri (PLUR). These companies are all part of the "medical" sector.

ZIVO Bioscience vs.

Surrozen (NASDAQ:SRZN) and ZIVO Bioscience (NASDAQ:ZIVO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

ZIVO Bioscience has lower revenue, but higher earnings than Surrozen. ZIVO Bioscience is trading at a lower price-to-earnings ratio than Surrozen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surrozen$12.50M1.53-$43.04M-$17.39-0.54
ZIVO Bioscience$30K746.67-$7.78M-$4.59-1.74

In the previous week, Surrozen had 3 more articles in the media than ZIVO Bioscience. MarketBeat recorded 3 mentions for Surrozen and 0 mentions for ZIVO Bioscience. ZIVO Bioscience's average media sentiment score of 0.56 beat Surrozen's score of 0.00 indicating that Surrozen is being referred to more favorably in the media.

Company Overall Sentiment
Surrozen Positive
ZIVO Bioscience Neutral

66.6% of Surrozen shares are held by institutional investors. Comparatively, 12.8% of ZIVO Bioscience shares are held by institutional investors. 35.0% of Surrozen shares are held by company insiders. Comparatively, 13.4% of ZIVO Bioscience shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

ZIVO Bioscience received 96 more outperform votes than Surrozen when rated by MarketBeat users. Likewise, 61.11% of users gave ZIVO Bioscience an outperform vote while only 16.67% of users gave Surrozen an outperform vote.

CompanyUnderperformOutperform
SurrozenOutperform Votes
3
16.67%
Underperform Votes
15
83.33%
ZIVO BioscienceOutperform Votes
99
61.11%
Underperform Votes
63
38.89%

Surrozen's return on equity of 0.00% beat ZIVO Bioscience's return on equity.

Company Net Margins Return on Equity Return on Assets
SurrozenN/A -82.43% -69.74%
ZIVO Bioscience N/A N/A -691.99%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surrozen
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
ZIVO Bioscience
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Surrozen has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500. Comparatively, ZIVO Bioscience has a beta of 0.2, suggesting that its stock price is 80% less volatile than the S&P 500.

Summary

Surrozen beats ZIVO Bioscience on 8 of the 14 factors compared between the two stocks.

Get ZIVO Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZIVO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZIVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZIVO vs. The Competition

MetricZIVO BioscienceBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$22.40M$2.61B$4.84B$7.32B
Dividend YieldN/A2.31%2.93%3.99%
P/E Ratio-1.7416.00174.4114.79
Price / Sales746.67305.272,456.8581.89
Price / CashN/A145.7646.2534.42
Price / Book-9.883.744.564.15
Net Income-$7.78M-$46.10M$103.85M$214.00M
7 Day PerformanceN/A-8.96%-4.48%-3.51%
1 Month Performance-9.30%-12.62%-6.67%-5.50%
1 Year Performance-55.41%3.48%7.75%3.54%

ZIVO Bioscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRZN
Surrozen
2.2212 of 5 stars
$11.01
-3.0%
N/A-11.7%$22.46M$12.50M-0.6374News Coverage
APTO
Aptose Biosciences
1.0928 of 5 stars
$1.38
-2.1%
$19.80
+1,334.8%
-83.6%$21.69MN/A-0.1831Gap Down
AIM
AIM ImmunoTech
0 of 5 stars
$0.56
+12.0%
N/A-13.7%$27.84M$200,000.00-0.9322High Trading Volume
EVAX
Evaxion Biotech A/S
2.1167 of 5 stars
$3.99
+0.8%
$11.00
+175.7%
-70.3%$16.16M$70,000.00-0.5963Gap Up
SNTI
Senti Biosciences
2.1381 of 5 stars
$0.35
flat
$6.00
+1,604.5%
-69.3%$16.11M$2.56M-0.2248Positive News
NKGN
NKGen Biotech
0 of 5 stars
$1.26
-3.8%
N/AN/A$28.68MN/A0.00N/ANews Coverage
Gap Down
CRTX
Cortexyme
0 of 5 stars
$0.99
-7.5%
N/A-29.1%$29.85MN/A-0.3355Gap Down
IKT
Inhibikase Therapeutics
0.9923 of 5 stars
$2.19
+2.8%
$27.00
+1,132.9%
-41.0%$14.19M$260,000.00-0.628News Coverage
COEP
Coeptis Therapeutics
1.2127 of 5 stars
$0.39
flat
$3.50
+797.4%
-76.7%$14.08M$80,000.00-0.464News Coverage
PLUR
Pluri
0 of 5 stars
$5.96
+4.9%
N/A-30.1%$30.87M$290,000.00-1.28123Gap Down

Related Companies and Tools

This page (NASDAQ:ZIVO) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners